Differential diagnosis of suspected multiple sclerosis: a consensus approach von Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH

Volltext

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration von Kearney, H, Rocca, MA, Valsasina, P, Balk, L, Sastre-Garriga, J, Reinhardt, J, Ruggieri, S, Rovira, A, Stippich, C, Kappos, L, Sprenger, T, Tortorella, P, Rovaris, M, Gasperini, C, Montalban, X, Geurts, JJG, Polman, CH, Barkhof, F, Filippi, M, Altmann, DR, Ciccarelli, O, Miller, DH, Chard, DT

Volltext

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis von O'CONNOR, P. W, GOODMAN, A, KAPPOS, L, LUBLIN, F. D, MILLER, D. H, POLMAN, C, RUDICK, R. A, ASCHENBACH, W, LUCAS, N

Volltext

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis von Fisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., Miller, D. H.

Volltext

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis von Montalban, X., Gold, R., Thompson, A. J., Otero‐Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S., Selmaj, K., Siva, A., Sorensen, P. S., Sormani, M. P., Thalheim, C., Wiendl, H., Zipp, F.

Volltext

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI von FARRELL, R. A, ANTONY, D, WALL, G. R, CLARK, D. A, FISNIKU, L, SWANTON, J, KHALEELI, Z, SCHMIERER, K, MILLER, D. H, GIOVANNONI, G

Volltext

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes von KAPPOS, L, POLMAN, C. H, POHL, C, SANDBRINK, R, FREEDMAN, M. S, EDAN, G, HARTUNG, H. P, MILLER, D. H, MONTALBAN, X, BARKHOF, F, BAUER, L, JAKOBS, P

Volltext

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes von DE STEFANO, N, GIORGIO, A, DINACCI, D, TEDESCHI, G, GASS, A, MONTALBAN, X, ROVIRA, A, THOMPSON, A, COMI, G, MILLER, D. H, FILIPPI, M, BATTAGLINI, M, ROVARIS, M, SORMANI, M. P, BARKHOF, F, KORTEWEG, T, ENZINGER, C, FAZEKAS, F, CALABRESE, M

Volltext

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS von MILLER, D. H, SOON, D, KAPPOS, L, HUTCHINSON, M, HAVRDOVA, E, LUBLIN, F. D, GIOVANNONI, G, WAJGT, A, RUDICK, R, LYNN, F, PANZARA, M. A, SANDROCK, A. W, FERNANDO, K. T, MACMANUS, D. G, BARKER, G. J, YOUSRY, T. A, FISHER, E, O'CONNOR, P. W, PHILLIPS, J. T, POLMAN, C. H

Volltext

Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome von Brownlee, WJ, Altmann, DR, Alves Da Mota, P, Swanton, JK, Miszkiel, KA, Wheeler-Kingshott, CAM Gandini, Ciccarelli, O, Miller, DH

Volltext

MRI criteria for MS in patients with clinically isolated syndromes von MONTALBAN, X, TINTORE, M, ROVARIS, M, DE STEFANO, N, THOMPSON, A, YOUSRY, T, ROVIRA, A, MILLER, D. H, SWANTON, J, BARKHOF, F, FAZEKAS, F, FILIPPI, M, FREDERIKSEN, J, KAPPOS, L, PALACE, J, POLMAN, C

Volltext

GLANCE : Results of a phase 2, randomized, double-blind, placebo-controlled study von GOODMAN, A. D, ROSSMAN, H, PANZARA, M. A, SANDROCK, A. W, BAR-OR, A, MILLER, A, MILLER, D. H, SCHMIERER, K, LUBLIN, F, KHAN, O, BORMANN, N. M, YANG, M

Volltext

Diffusion MRI in multiple sclerosis von ROVARIS, M, GASS, A, BAMMER, R, HICKMAN, S. J, CICCARELLI, O, MILLER, D. H, FILIPPI, M

Volltext

Energy-temperature uncertainty relation in quantum thermodynamics von Miller, H. J. D., Anders, J.

Volltext

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis von ALTMANN, D. R, JASPERSE, B, WAGNER, K, YOUSRY, T. A, MILLER, D. H, BARKHOF, F, BECKMANN, K, FILIPPI, M, KAPPOS, L. D, MOLYNEUX, P, POLMAN, C. H, POZZILLI, C, THOMPSON, A. J

Volltext

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance von Miller, David H., Barkhof, Frederik, Frank, Joseph A., Parker, Geoffrey J. M., Thompson, Alan J.

Volltext

MRI T2 lesion burden in multiple sclerosis : A plateauing relationship with clinical disability von LI, D. K. B, HELD, U, WOLINSKY, J. S, FILIPPI, M, PETKAU, J, DAUMER, M, BARKHOF, F, FAZEKAS, F, FRANK, J. A, KAPPOS, L, MILLER, D. H, SIMON, J. H

Volltext

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy von STÜVE, O, CRAVENS, P. D, MACMANUS, D, MILLER, D. H, RADÜ, E. W, CAMERON, E. M, MONSON, N. L, ZHANG, S, KIM, R, HEMMER, B, FROHMAN, E. M, PHILLIPS, J. T, REMINGTON, G. M, VON GELDERN, G, CEPOK, S, SINGH, M. P, COHEN TERVAERT, J. W, DE BAETS, M

Volltext

Brain atrophy in clinically early relapsing-remitting multiple sclerosis von CHARD, D. T, GRIFFIN, C. M, PARKER, G. J. M, KAPOOR, R, THOMPSON, A. J, MILLER, D. H

Volltext

The role of magnetic resonance techniques in understanding and managing multiple sclerosis von MILLER, D. H, GROSSMAN, R. I, REINGOLD, S. C, MCFARLAND, H. F

Volltext